Flow Medical Solutions, Inc.
Flow Medical is dedicated to transforming care for pulmonary embolism through innovative therapeutic solutions that improve patient outcomes and streamline treatment. Based in Chicago, IL, the company is at the forefront of cardiovascular treatment innovation, developing advanced medical devices for PE and VTE treatment.
Industries
Nr. of Employees
small (1-50)
Products
Integrated steerable angiography–infusion–monitoring thrombolytic catheter (development-stage)
A minimally invasive, steerable endovascular catheter that combines angiographic compatibility, targeted infusion ports for thrombolytic delivery, and real-time monitoring to enable personalized catheter-directed thrombolysis for pulmonary embolism.
Integrated steerable angiography–infusion–monitoring thrombolytic catheter (development-stage)
A minimally invasive, steerable endovascular catheter that combines angiographic compatibility, targeted infusion ports for thrombolytic delivery, and real-time monitoring to enable personalized catheter-directed thrombolysis for pulmonary embolism.
Services
Partnerships with medical centers and investigators to conduct early clinical evaluations and first-in-human studies of investigational endovascular therapies.
End-to-end development of minimally invasive endovascular devices for pulmonary embolism, including design, engineering, and validation testing.
Partnerships with medical centers and investigators to conduct early clinical evaluations and first-in-human studies of investigational endovascular therapies.
End-to-end development of minimally invasive endovascular devices for pulmonary embolism, including design, engineering, and validation testing.
Expertise Areas
- Catheter-directed thrombolysis and endovascular therapy
- Medical device design and engineering for interventional cardiology/radiology
- Clinical trial planning and first-in-human studies
- Regulatory strategy for medical devices
Key Technologies
- Steerable catheter systems
- Catheter-directed thrombolysis
- Integrated infusion delivery ports
- Real-time procedural monitoring and feedback
News & Updates
Flow Medical announced the closing of a $5 million seed funding round to accelerate the development and launch of its PE device, aiming to enhance patient outcomes and advance cardiovascular care. The funding was supported by strategic investors including the University of Chicago Medical Center's UCM Ventures.
Flow Medical completed a $2 million Friends and Family funding round to develop its novel thrombolysis catheter for PE treatment. The technology was conceived by physicians at the University of Chicago Medical Center and aims to provide targeted, precise therapy for PE patients.
Jennifer Fried has been named CEO and Co-Founder of Flow Medical. She is an experienced healthcare entrepreneur and investor, previously leading Explorer Surgical. Her leadership is expected to accelerate the company's efforts to bring its innovative device to market.
Flow Medical announced the closing of a $5 million seed funding round to accelerate the development and launch of its PE device, aiming to enhance patient outcomes and advance cardiovascular care. The funding was supported by strategic investors including the University of Chicago Medical Center's UCM Ventures.
Flow Medical completed a $2 million Friends and Family funding round to develop its novel thrombolysis catheter for PE treatment. The technology was conceived by physicians at the University of Chicago Medical Center and aims to provide targeted, precise therapy for PE patients.
Jennifer Fried has been named CEO and Co-Founder of Flow Medical. She is an experienced healthcare entrepreneur and investor, previously leading Explorer Surgical. Her leadership is expected to accelerate the company's efforts to bring its innovative device to market.